TARS in the 13F filings
Tarsus Pharmaceuticals Inc · CUSIP 87650L103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 4 listed it in both
- Shares listed
- 6,747,547
- combined, among listed positions
- Reported value
- $474m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +833,695.
Managers listing TARS in Q1 2026
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 564,579 shares now+447,575
- Janus Henderson Group Ltdexisting position · 2,240,963 shares now+310,638
- Squarepoint Ops LLCexisting position · 241,033 shares now+219,200
- Point72 Asset Management LPexisting position · 226,251 shares now+188,623
- D. E. Shaw & Co.existing position · 791,146 shares now+175,990
Reductions
- Invesco Ltdexisting position · 742,497 shares now-269,860
- T. Rowe Price Associates Incexisting position · 274,804 shares now-243,976
- Artisan Partners LPexisting position · 307,307 shares now-129,269
- Caxton Associates LLPexisting position · 15,163 shares now-25,792
- Walleye Capital LLCexisting position · 15,184 shares now-25,089
New positions and exits
New (3)
Exited (6)
- Voloridge Investment Management LLCwas $1.9m
- Tudor Investment Corpwas $1.9m
- Schonfeld Strategic Advisors LLCwas $1.7m
- Jane Street Group LLCwas $1.7m
- Winton Group Ltdwas $528k
- Brevan Howard Capital Management LPwas $365k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 1 | $397k | n.a. | n.a. |
| Q3 2023 | 2 | $14m | n.a. | n.a. |
| Q4 2023 | 2 | $13m | 0 | 2 |
| Q1 2024 | 2 | $31m | 1 | 1 |
| Q2 2024 | 2 | $35m | 2 | 0 |
| Q3 2024 | 5 | $62m | 5 | 0 |
| Q4 2024 | 4 | $46m | 2 | 2 |
| Q1 2025 | 1 | $31m | 0 | 1 |
| Q2 2025 | 3 | $98m | 2 | 1 |
| Q3 2025 | 3 | $122m | 1 | 1 |
| Q4 2025 | 4 | $202m | 18 | 10 |
| Q1 2026 | 4 | $184m | 14 | 14 |
| Q2 2026 | 4 | $201m | 16 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TARS and GILD →TARS and AMGN →TARS and ARGX →Choose a stock to compare with TARS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TARS, latest filings →Back to the 13F Explorer →